0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pets Anti-infective Drugs Market Research Report 2026
Published Date: 2026-04-02
|
Report Code: QYRE-Auto-8C9403
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pets Anti infective Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pets Anti-infective Drugs Market Research Report 2026

Code: QYRE-Auto-8C9403
Report
2026-04-02
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pets Anti-infective Drugs Market Size

The global Pets Anti-infective Drugs market was valued at US$ 2434 million in 2025 and is anticipated to reach US$ 7185 million by 2032, at a CAGR of 17.0% from 2026 to 2032.

Pets Anti-infective Drugs Market

Pets Anti-infective Drugs Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pets Anti-infective Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.
The pet anti-infective drug market is a growing area. With the expansion of the global pet market and the improvement of pet health awareness, this market has shown great development potential.
The pet anti-infective drug market is dominated by many well-known companies, such as Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products and Ceva Santé Animale, which have deep technical accumulation and market experience in veterinary drug research and development, production and market operation.
The market concentration is high, and a few companies occupy a large market share, but with the entry of new companies and the intensification of market competition, the market pattern may change.
Pet anti-infective drugs mainly include antibiotics, antibacterial drugs and other types, which are used to prevent and treat various bacterial infections of pets. These drugs play an important role in improving the quality of life of pets and prolonging their lifespan.
With the advancement of science and technology and the increase in R&D investment, new products and new therapies will continue to emerge in the pet anti-infective drug market. These innovative products will have better efficacy, lower side effects and higher safety, meeting the diverse needs of pet owners.
With the development of precision medicine, the pet anti-infective drug market will pay more attention to personalized treatment in the future. Providing customized anti-infection treatment plans for pets of different types, ages, and health conditions will become an important direction for market development.
This report delivers a comprehensive overview of the global Pets Anti-infective Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pets Anti-infective Drugs. The Pets Anti-infective Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pets Anti-infective Drugs market comprehensively. Regional market sizes by Administration Method, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pets Anti-infective Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Administration Method, by Application, and by region.
Market Segmentation

Scope of Pets Anti-infective Drugs Market Report

Report Metric Details
Report Name Pets Anti-infective Drugs Market
Accounted market size in 2025 US$ 2434 million
Forecasted market size in 2032 US$ 7185 million
CAGR 17.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Administration Method
  • External Use
  • Internal Use
  • Injection
by Application
  • Dog
  • Cat
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Santé Animale, Vetoquinol, Nanjing Jindun Animal, Wuhan Chopperlvya, Bimeda Animal Health, Ouro Fino Saude, Norbrook, Hanvet Pet Health, Wuhan Hvsen Biotechnology, Zhejiang Hisun Animal Healthcare Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Administration Method, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Pets Anti-infective Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Pets Anti-infective Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Administration Method, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Pets Anti-infective Drugs Market growing?

Ans: The Pets Anti-infective Drugs Market witnessing a CAGR of 17.0% during the forecast period 2026-2032.

What is the Pets Anti-infective Drugs Market size in 2032?

Ans: The Pets Anti-infective Drugs Market size in 2032 will be US$ 7185 million.

Who are the main players in the Pets Anti-infective Drugs Market report?

Ans: The main players in the Pets Anti-infective Drugs Market are Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Santé Animale, Vetoquinol, Nanjing Jindun Animal, Wuhan Chopperlvya, Bimeda Animal Health, Ouro Fino Saude, Norbrook, Hanvet Pet Health, Wuhan Hvsen Biotechnology, Zhejiang Hisun Animal Healthcare Products

What are the Application segmentation covered in the Pets Anti-infective Drugs Market report?

Ans: The Applications covered in the Pets Anti-infective Drugs Market report are Dog, Cat, Others

1 Pets Anti-infective Drugs Market Overview
1.1 Product Definition
1.2 Pets Anti-infective Drugs by Administration Method
1.2.1 Global Pets Anti-infective Drugs Market Value by Administration Method: 2025 vs 2032
1.2.2 External Use
1.2.3 Internal Use
1.2.4 Injection
1.3 Pets Anti-infective Drugs by Application
1.3.1 Global Pets Anti-infective Drugs Market Value by Application: 2025 vs 2032
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Global Pets Anti-infective Drugs Market Size Estimates and Forecasts
1.4.1 Global Pets Anti-infective Drugs Revenue 2021–2032
1.4.2 Global Pets Anti-infective Drugs Sales 2021–2032
1.4.3 Global Pets Anti-infective Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pets Anti-infective Drugs Market Competition by Manufacturers
2.1 Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pets Anti-infective Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pets Anti-infective Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pets Anti-infective Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pets Anti-infective Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Pets Anti-infective Drugs, Date of Entry into the Industry
2.8 Global Pets Anti-infective Drugs Market Competitive Situation and Trends
2.8.1 Global Pets Anti-infective Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pets Anti-infective Drugs Players Market Share by Revenue
2.8.3 Global Pets Anti-infective Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pets Anti-infective Drugs Market Scenario by Region
3.1 Global Pets Anti-infective Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pets Anti-infective Drugs Sales by Region: 2021–2032
3.2.1 Global Pets Anti-infective Drugs Sales by Region: 2021–2026
3.2.2 Global Pets Anti-infective Drugs Sales by Region: 2027–2032
3.3 Global Pets Anti-infective Drugs Revenue by Region: 2021–2032
3.3.1 Global Pets Anti-infective Drugs Revenue by Region: 2021–2026
3.3.2 Global Pets Anti-infective Drugs Revenue by Region: 2027–2032
3.4 North America Pets Anti-infective Drugs Market Facts & Figures by Country
3.4.1 North America Pets Anti-infective Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pets Anti-infective Drugs Sales by Country (2021–2032)
3.4.3 North America Pets Anti-infective Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pets Anti-infective Drugs Market Facts & Figures by Country
3.5.1 Europe Pets Anti-infective Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pets Anti-infective Drugs Sales by Country (2021–2032)
3.5.3 Europe Pets Anti-infective Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pets Anti-infective Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Pets Anti-infective Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pets Anti-infective Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Pets Anti-infective Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pets Anti-infective Drugs Market Facts & Figures by Country
3.7.1 Latin America Pets Anti-infective Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pets Anti-infective Drugs Sales by Country (2021–2032)
3.7.3 Latin America Pets Anti-infective Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pets Anti-infective Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pets Anti-infective Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pets Anti-infective Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Administration Method
4.1 Global Pets Anti-infective Drugs Sales by Administration Method (2021–2032)
4.1.1 Global Pets Anti-infective Drugs Sales by Administration Method (2021–2026)
4.1.2 Global Pets Anti-infective Drugs Sales by Administration Method (2027–2032)
4.1.3 Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2021–2032)
4.2 Global Pets Anti-infective Drugs Revenue by Administration Method (2021–2032)
4.2.1 Global Pets Anti-infective Drugs Revenue by Administration Method (2021–2026)
4.2.2 Global Pets Anti-infective Drugs Revenue by Administration Method (2027–2032)
4.2.3 Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2021–2032)
4.3 Global Pets Anti-infective Drugs Price by Administration Method (2021–2032)
5 Segment by Application
5.1 Global Pets Anti-infective Drugs Sales by Application (2021–2032)
5.1.1 Global Pets Anti-infective Drugs Sales by Application (2021–2026)
5.1.2 Global Pets Anti-infective Drugs Sales by Application (2027–2032)
5.1.3 Global Pets Anti-infective Drugs Sales Market Share by Application (2021–2032)
5.2 Global Pets Anti-infective Drugs Revenue by Application (2021–2032)
5.2.1 Global Pets Anti-infective Drugs Revenue by Application (2021–2026)
5.2.2 Global Pets Anti-infective Drugs Revenue by Application (2027–2032)
5.2.3 Global Pets Anti-infective Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Pets Anti-infective Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zoetis Pets Anti-infective Drugs Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Pets Anti-infective Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Elanco
6.3.1 Elanco Company Information
6.3.2 Elanco Description and Business Overview
6.3.3 Elanco Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Elanco Pets Anti-infective Drugs Product Portfolio
6.3.5 Elanco Recent Developments/Updates
6.4 Virbac
6.4.1 Virbac Company Information
6.4.2 Virbac Description and Business Overview
6.4.3 Virbac Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Virbac Pets Anti-infective Drugs Product Portfolio
6.4.5 Virbac Recent Developments/Updates
6.5 Dechra Veterinary Products
6.5.1 Dechra Veterinary Products Company Information
6.5.2 Dechra Veterinary Products Description and Business Overview
6.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
6.5.5 Dechra Veterinary Products Recent Developments/Updates
6.6 Ceva Santé Animale
6.6.1 Ceva Santé Animale Company Information
6.6.2 Ceva Santé Animale Description and Business Overview
6.6.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio
6.6.5 Ceva Santé Animale Recent Developments/Updates
6.7 Vetoquinol
6.7.1 Vetoquinol Company Information
6.7.2 Vetoquinol Description and Business Overview
6.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
6.7.5 Vetoquinol Recent Developments/Updates
6.8 Nanjing Jindun Animal
6.8.1 Nanjing Jindun Animal Company Information
6.8.2 Nanjing Jindun Animal Description and Business Overview
6.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
6.8.5 Nanjing Jindun Animal Recent Developments/Updates
6.9 Wuhan Chopperlvya
6.9.1 Wuhan Chopperlvya Company Information
6.9.2 Wuhan Chopperlvya Description and Business Overview
6.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
6.9.5 Wuhan Chopperlvya Recent Developments/Updates
6.10 Bimeda Animal Health
6.10.1 Bimeda Animal Health Company Information
6.10.2 Bimeda Animal Health Description and Business Overview
6.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
6.10.5 Bimeda Animal Health Recent Developments/Updates
6.11 Ouro Fino Saude
6.11.1 Ouro Fino Saude Company Information
6.11.2 Ouro Fino Saude Description and Business Overview
6.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
6.11.5 Ouro Fino Saude Recent Developments/Updates
6.12 Norbrook
6.12.1 Norbrook Company Information
6.12.2 Norbrook Description and Business Overview
6.12.3 Norbrook Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Norbrook Pets Anti-infective Drugs Product Portfolio
6.12.5 Norbrook Recent Developments/Updates
6.13 Hanvet Pet Health
6.13.1 Hanvet Pet Health Company Information
6.13.2 Hanvet Pet Health Description and Business Overview
6.13.3 Hanvet Pet Health Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hanvet Pet Health Pets Anti-infective Drugs Product Portfolio
6.13.5 Hanvet Pet Health Recent Developments/Updates
6.14 Wuhan Hvsen Biotechnology
6.14.1 Wuhan Hvsen Biotechnology Company Information
6.14.2 Wuhan Hvsen Biotechnology Description and Business Overview
6.14.3 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product Portfolio
6.14.5 Wuhan Hvsen Biotechnology Recent Developments/Updates
6.15 Zhejiang Hisun Animal Healthcare Products
6.15.1 Zhejiang Hisun Animal Healthcare Products Company Information
6.15.2 Zhejiang Hisun Animal Healthcare Products Description and Business Overview
6.15.3 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product Portfolio
6.15.5 Zhejiang Hisun Animal Healthcare Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pets Anti-infective Drugs Industry Chain Analysis
7.2 Pets Anti-infective Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pets Anti-infective Drugs Production Mode & Process Analysis
7.4 Pets Anti-infective Drugs Sales and Marketing
7.4.1 Pets Anti-infective Drugs Sales Channels
7.4.2 Pets Anti-infective Drugs Distributors
7.5 Pets Anti-infective Drugs Customer Analysis
8 Pets Anti-infective Drugs Market Dynamics
8.1 Pets Anti-infective Drugs Industry Trends
8.2 Pets Anti-infective Drugs Market Drivers
8.3 Pets Anti-infective Drugs Market Challenges
8.4 Pets Anti-infective Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pets Anti-infective Drugs Market Value by Administration Method (US$ Million), 2025 vs 2032
 Table 2. Global Pets Anti-infective Drugs Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Pets Anti-infective Drugs Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Pets Anti-infective Drugs Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Pets Anti-infective Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Pets Anti-infective Drugs Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Pets Anti-infective Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Pets Anti-infective Drugs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Pets Anti-infective Drugs, Product Types and Applications
 Table 12. Global Key Manufacturers of Pets Anti-infective Drugs, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pets Anti-infective Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pets Anti-infective Drugs Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pets Anti-infective Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Pets Anti-infective Drugs Sales by Region (K Units), 2021–2026
 Table 18. Global Pets Anti-infective Drugs Sales Market Share by Region (2021–2026)
 Table 19. Global Pets Anti-infective Drugs Sales by Region (K Units), 2027–2032
 Table 20. Global Pets Anti-infective Drugs Sales Market Share by Region (2027–2032)
 Table 21. Global Pets Anti-infective Drugs Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Pets Anti-infective Drugs Revenue Market Share by Region (2021–2026)
 Table 23. Global Pets Anti-infective Drugs Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Pets Anti-infective Drugs Revenue Market Share by Region (2027–2032)
 Table 25. North America Pets Anti-infective Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Pets Anti-infective Drugs Sales by Country (K Units), 2021–2026
 Table 27. North America Pets Anti-infective Drugs Sales by Country (K Units), 2027–2032
 Table 28. North America Pets Anti-infective Drugs Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Pets Anti-infective Drugs Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Pets Anti-infective Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Pets Anti-infective Drugs Sales by Country (K Units), 2021–2026
 Table 32. Europe Pets Anti-infective Drugs Sales by Country (K Units), 2027–2032
 Table 33. Europe Pets Anti-infective Drugs Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Pets Anti-infective Drugs Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Pets Anti-infective Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Pets Anti-infective Drugs Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Pets Anti-infective Drugs Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Pets Anti-infective Drugs Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Pets Anti-infective Drugs Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Pets Anti-infective Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Pets Anti-infective Drugs Sales by Country (K Units), 2021–2026
 Table 42. Latin America Pets Anti-infective Drugs Sales by Country (K Units), 2027–2032
 Table 43. Latin America Pets Anti-infective Drugs Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Pets Anti-infective Drugs Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Pets Anti-infective Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Pets Anti-infective Drugs Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Pets Anti-infective Drugs Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Pets Anti-infective Drugs Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Pets Anti-infective Drugs Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Pets Anti-infective Drugs Sales (K Units) by Administration Method (2021–2026)
 Table 51. Global Pets Anti-infective Drugs Sales (K Units) by Administration Method (2027–2032)
 Table 52. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2021–2026)
 Table 53. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2027–2032)
 Table 54. Global Pets Anti-infective Drugs Revenue (US$ Million) by Administration Method (2021–2026)
 Table 55. Global Pets Anti-infective Drugs Revenue (US$ Million) by Administration Method (2027–2032)
 Table 56. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2021–2026)
 Table 57. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2027–2032)
 Table 58. Global Pets Anti-infective Drugs Price (US$/Unit) by Administration Method (2021–2026)
 Table 59. Global Pets Anti-infective Drugs Price (US$/Unit) by Administration Method (2027–2032)
 Table 60. Global Pets Anti-infective Drugs Sales (K Units) by Application (2021–2026)
 Table 61. Global Pets Anti-infective Drugs Sales (K Units) by Application (2027–2032)
 Table 62. Global Pets Anti-infective Drugs Sales Market Share by Application (2021–2026)
 Table 63. Global Pets Anti-infective Drugs Sales Market Share by Application (2027–2032)
 Table 64. Global Pets Anti-infective Drugs Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Pets Anti-infective Drugs Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Pets Anti-infective Drugs Revenue Market Share by Application (2021–2026)
 Table 67. Global Pets Anti-infective Drugs Revenue Market Share by Application (2027–2032)
 Table 68. Global Pets Anti-infective Drugs Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Pets Anti-infective Drugs Price (US$/Unit) by Application (2027–2032)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Zoetis Pets Anti-infective Drugs Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Merck Pets Anti-infective Drugs Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Elanco Company Information
 Table 81. Elanco Description and Business Overview
 Table 82. Elanco Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Elanco Pets Anti-infective Drugs Product
 Table 84. Elanco Recent Developments/Updates
 Table 85. Virbac Company Information
 Table 86. Virbac Description and Business Overview
 Table 87. Virbac Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Virbac Pets Anti-infective Drugs Product
 Table 89. Virbac Recent Developments/Updates
 Table 90. Dechra Veterinary Products Company Information
 Table 91. Dechra Veterinary Products Description and Business Overview
 Table 92. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Dechra Veterinary Products Pets Anti-infective Drugs Product
 Table 94. Dechra Veterinary Products Recent Developments/Updates
 Table 95. Ceva Santé Animale Company Information
 Table 96. Ceva Santé Animale Description and Business Overview
 Table 97. Ceva Santé Animale Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Ceva Santé Animale Pets Anti-infective Drugs Product
 Table 99. Ceva Santé Animale Recent Developments/Updates
 Table 100. Vetoquinol Company Information
 Table 101. Vetoquinol Description and Business Overview
 Table 102. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Vetoquinol Pets Anti-infective Drugs Product
 Table 104. Vetoquinol Recent Developments/Updates
 Table 105. Nanjing Jindun Animal Company Information
 Table 106. Nanjing Jindun Animal Description and Business Overview
 Table 107. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Nanjing Jindun Animal Pets Anti-infective Drugs Product
 Table 109. Nanjing Jindun Animal Recent Developments/Updates
 Table 110. Wuhan Chopperlvya Company Information
 Table 111. Wuhan Chopperlvya Description and Business Overview
 Table 112. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Wuhan Chopperlvya Pets Anti-infective Drugs Product
 Table 114. Wuhan Chopperlvya Recent Developments/Updates
 Table 115. Bimeda Animal Health Company Information
 Table 116. Bimeda Animal Health Description and Business Overview
 Table 117. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Bimeda Animal Health Pets Anti-infective Drugs Product
 Table 119. Bimeda Animal Health Recent Developments/Updates
 Table 120. Ouro Fino Saude Company Information
 Table 121. Ouro Fino Saude Description and Business Overview
 Table 122. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Ouro Fino Saude Pets Anti-infective Drugs Product
 Table 124. Ouro Fino Saude Recent Developments/Updates
 Table 125. Norbrook Company Information
 Table 126. Norbrook Description and Business Overview
 Table 127. Norbrook Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Norbrook Pets Anti-infective Drugs Product
 Table 129. Norbrook Recent Developments/Updates
 Table 130. Hanvet Pet Health Company Information
 Table 131. Hanvet Pet Health Description and Business Overview
 Table 132. Hanvet Pet Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Hanvet Pet Health Pets Anti-infective Drugs Product
 Table 134. Hanvet Pet Health Recent Developments/Updates
 Table 135. Wuhan Hvsen Biotechnology Company Information
 Table 136. Wuhan Hvsen Biotechnology Description and Business Overview
 Table 137. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product
 Table 139. Wuhan Hvsen Biotechnology Recent Developments/Updates
 Table 140. Zhejiang Hisun Animal Healthcare Products Company Information
 Table 141. Zhejiang Hisun Animal Healthcare Products Description and Business Overview
 Table 142. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product
 Table 144. Zhejiang Hisun Animal Healthcare Products Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Pets Anti-infective Drugs Distributors List
 Table 148. Pets Anti-infective Drugs Customers List
 Table 149. Pets Anti-infective Drugs Market Trends
 Table 150. Pets Anti-infective Drugs Market Drivers
 Table 151. Pets Anti-infective Drugs Market Challenges
 Table 152. Pets Anti-infective Drugs Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pets Anti-infective Drugs
 Figure 2. Global Pets Anti-infective Drugs Market Value by Administration Method (US$ Million), 2021–2032
 Figure 3. Global Pets Anti-infective Drugs Market Share by Administration Method: 2025 & 2032
 Figure 4. External Use Product Picture
 Figure 5. Internal Use Product Picture
 Figure 6. Injection Product Picture
 Figure 7. Global Pets Anti-infective Drugs Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Pets Anti-infective Drugs Market Share by Application: 2025 & 2032
 Figure 9. Dog
 Figure 10. Cat
 Figure 11. Others
 Figure 12. Global Pets Anti-infective Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Pets Anti-infective Drugs Market Size (US$ Million), 2021–2032
 Figure 14. Global Pets Anti-infective Drugs Sales (K Units), 2021–2032
 Figure 15. Global Pets Anti-infective Drugs Average Price (US$/Unit), 2021–2032
 Figure 16. Pets Anti-infective Drugs Report Years Considered
 Figure 17. Pets Anti-infective Drugs Sales Share by Manufacturers in 2025
 Figure 18. Global Pets Anti-infective Drugs Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Pets Anti-infective Drugs Players: Market Share by Revenue in Pets Anti-infective Drugs in 2025
 Figure 20. Pets Anti-infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Pets Anti-infective Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Pets Anti-infective Drugs Sales Market Share by Country (2021–2032)
 Figure 23. North America Pets Anti-infective Drugs Revenue Market Share by Country (2021–2032)
 Figure 24. United States Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Pets Anti-infective Drugs Sales Market Share by Country (2021–2032)
 Figure 27. Europe Pets Anti-infective Drugs Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Pets Anti-infective Drugs Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Pets Anti-infective Drugs Revenue Market Share by Region (2021–2032)
 Figure 35. China Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Pets Anti-infective Drugs Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Pets Anti-infective Drugs Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Pets Anti-infective Drugs Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Pets Anti-infective Drugs Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Pets Anti-infective Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Pets Anti-infective Drugs by Administration Method (2021–2032)
 Figure 55. Global Revenue Market Share of Pets Anti-infective Drugs by Administration Method (2021–2032)
 Figure 56. Global Pets Anti-infective Drugs Price (US$/Unit) by Administration Method (2021–2032)
 Figure 57. Global Sales Market Share of Pets Anti-infective Drugs by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Pets Anti-infective Drugs by Application (2021–2032)
 Figure 59. Global Pets Anti-infective Drugs Price (US$/Unit) by Application (2021–2032)
 Figure 60. Pets Anti-infective Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure